Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | AGK-2 | CTRPv2 | pan-cancer | AAC | -0.014 | 0.7 |
mRNA | BRD-K41597374 | CTRPv2 | pan-cancer | AAC | -0.013 | 0.7 |
mRNA | Crizotinib | GDSC1000 | pan-cancer | AAC | 0.019 | 0.7 |
mRNA | Vorinostat | GDSC1000 | pan-cancer | AAC | 0.011 | 0.7 |
mRNA | YM-155 | GDSC1000 | pan-cancer | AAC | -0.012 | 0.7 |
mRNA | SMER-3 | CTRPv2 | pan-cancer | AAC | 0.013 | 0.7 |
mRNA | N9-isopropylolomoucine | CTRPv2 | pan-cancer | AAC | 0.013 | 0.7 |
mRNA | CIL70 | CTRPv2 | pan-cancer | AAC | -0.016 | 0.7 |
mRNA | IPR-456 | CTRPv2 | pan-cancer | AAC | -0.013 | 0.7 |
mRNA | selumetinib:UNC0638 (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.012 | 0.7 |